MAPT and Alzheimer disease: However, SCI/MCI and AD patients with a follow-up visit differed in terms of systolic blood pressure, hypertension (%), CSF/serum albumin ratio, and CSF AD biomarkers (Aβ1–42, P-tau, and T-tau).